Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide.

MLA

Ardura, Juan A., et al. “Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide.” Trends in Endocrinology & Metabolism, vol. 30, no. 10, Oct. 2019, pp. 756–66. EBSCOhost, https://doi.org/10.1016/j.tem.2019.07.014.

APA

Ardura, J. A., Portal-Núñez, S., Alonso, V., Bravo, B., & Gortazar, A. R. (2019). Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide. Trends in Endocrinology & Metabolism, 30(10), 756–766. https://doi.org/10.1016/j.tem.2019.07.014

Chicago

Ardura, Juan A., Sergio Portal-Núñez, Verónica Alonso, Beatriz Bravo, and Arancha R. Gortazar. 2019. “Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide.” Trends in Endocrinology & Metabolism 30 (10): 756–66. doi:10.1016/j.tem.2019.07.014.